IRCT20200818048444N3已完成1 期
Ivermectine effect in treatment of patients with COVID-19 disease
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Patients with diagnosis of COVID-19 disease
排除标准
- •History of allergy to ivermectin, and evidence for current helminthic disease
- •Advanced renal failure with GFR<30
- •Advanced liver failure
- •Advanced malignancy
- •Severe heart failure or active cardiac arrhythmia
研究者
相似试验
已完成
2 期
Ivermectin effect in treatment of patients with human fascioliasisFasciola.Infection due to FasciolaIRCT201105291155N13Vince chancellor for reaserch Guilan univercity of medical sciences40
招募中
2 期
Effect of ivermectin in COVID-19IRCT20200329046892N3Rasht University of Medical Sciences60
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375